Kracht, P. A. M. http://orcid.org/0000-0002-5794-9386
Arends, J. E.
van Erpecum, K. J.
Urbanus, A.
Willemse, J. A.
Hoepelman, A. I. M.
Croes, E. A.
Article History
Received: 23 April 2018
Accepted: 20 September 2018
First Online: 29 September 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AH: advisory boards: Abbvie, BMS, Gilead, Janssen, MSD; consultancy: AbbVie; financial support for HCV retrieval project from Abbvie, BMS, Gilead and MSD; JA: advisory boards: Abbvie, BMS, Gilead, Janssen, MSD and ViiV; research grants: AbbVie, BMS; KvE: advisory boards: Abbvie, BMS, Gilead, Janssen-Cilag; Support for HCV patient care path from Abbvie, Gilead, Janssen-Cilag. The other authors declare that they have no competing interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.